NASDAQ$AXON

Axon Enterprise Inc · Q1 2021 earnings

Q1 2021 earnings · · Investor relations

Briefing

Revenue increased driven by strong product demand and international expansion.

Axon Enterprise reported a strong start to 2021 with revenue growth of 33% year over year, driven by strong demand for TASER devices and software-heavy body camera bundles. The company is raising its full-year outlook.

  • Revenue of $195 million grew 33% year over year.
  • Annual Recurring Revenue up 39% to $242 million.
  • Gross margin of 63.3% improved 310 basis points year over year.
  • New products bookings up 130% year over year, and new market bookings up 35% year over year.

Headline financials

Total Revenue

$195M

Previous: $147M+32.5%
EPS (adj)

$0.31

Previous: $0.40-22.5%
Annual Recurring Revenue

$242M

No prior period
Capital Expenditures

-$10.5M

Previous: -$2.21M-376.3%
Free Cash Flow

-$58.4M

Previous: $1.87M-3233.4%
Net Income

-$47.9M

Previous: $4.07M-1276.2%
Operating Income

-$50.3M

Previous: -$800K-6182.8%
Gross Profit

$123M

Previous: $88.6M+39.2%
Cash & Equivalents

$155M

Previous: $157M-1.1%
Total Assets

$1.4B

Previous: $877M+60.1%
Stock-Based Comp

$89.6M

Previous: $20.2M+343.7%

Revenue & EPS history

Axon · Revenue · Quarterly

$195M

Q1 2021+32.5%vs Q1 2020
Beat estimate in 15 of 16 quarters(94%)
ActualEstimate

Revenue by segment

Axon · $99M total across 1 segment · Q1 2021

  • TASER
    $99M+30.4%

Forward guidance

Axon expects to achieve revenue in the range of $780 million to $820 million and Adjusted EBITDA to $140 million to $150 million for 2021.

Tailwinds

  • Revenue in the range of $780 million to $820 million.
  • Adjusted EBITDA to $140 million to $150 million.
  • Investments are yielding results ahead of expectations.
  • Continue investing for growth.
  • Early view of the business in 2022 includes approximately $920 million in revenue.

Headwinds

  • Inherent difficulty of forecasting certain types of expenses such as stock-based compensation and income tax expenses
  • Stock-based compensation expense to be at least $175 million for the full year.
  • Stock-based compensation expense may fluctuate significantly based on changes in the probability of attaining certain operational metrics or attainment of such metrics and with changes in the expected or actual timing of such attainment
  • Expectations for capital expenditures of approximately $65 million to $70 million in 2021 are unchanged.
  • These include investments to support capacity expansion and automation on TASER device and cartridge manufacturing

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2021

Historical avgQ1 2021

+3.4%

Avg return

Earnings day

+6.6%

Avg return

5 days after

+6.7%

Avg return

30 days after

55%

35 / 64 earnings

Positive

+31.3%

Q3 2024

Best reaction

-17.1%

Q4 2012

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+1.4%+3.1%+27.9%
Q4 2025+1.1%+29.3%-2.8%
Q3 2025+13.7%-17.2%-22.0%
Q1 2025+14.2%+20.4%+31.6%
Q4 2024+15.3%+5.9%+7.7%
Q3 2024+31.3%+29.5%+49.7%
Q2 2024+22.0%+27.6%+24.0%
Q1 2024-1.8%-4.7%-11.4%
Q4 2023+13.9%+15.7%+15.2%
Q3 2023+5.9%+0.5%+8.5%
Q2 2023+11.6%+17.6%+20.3%
Q1 2023-13.1%-9.2%-12.2%
Q4 2022+13.4%+13.3%+11.7%
Q3 2022+15.8%+23.2%+15.7%
Q2 2022+8.5%+11.4%+5.6%
Q1 2022-4.0%+11.8%+15.0%
Q4 2021+9.6%+16.1%+8.4%
Q3 2021+4.3%+6.8%-13.4%
Q2 2021+0.8%-3.8%-3.3%
Q1 2021-4.6%-6.6%-0.1%
Q4 2020+2.5%+2.9%-14.6%
Q3 2020+16.7%+13.3%+18.2%
Q2 2020-9.5%-14.5%-10.8%
Q1 2020+30.2%+26.2%+40.3%
Q4 2019-3.8%-2.9%-7.5%
Q3 2019+25.0%+22.5%+37.6%
Q2 2019-11.4%-10.3%-5.4%
Q1 2019-4.9%-1.0%+3.3%
Q4 2018-4.4%-6.2%-7.2%
Q3 2018-16.1%-13.6%-26.4%
Q2 2018-10.6%-8.1%+5.1%
Q1 2018+21.6%+27.4%+41.4%
Q4 2017+23.7%+37.6%+39.6%
Q3 2017-7.7%-8.9%+4.8%
Q2 2017-10.5%-13.1%-16.4%
Q1 2017+4.8%+3.8%-2.4%
Q4 2016-6.7%-12.5%-11.0%
Q3 2016+19.3%+22.3%+6.0%
Q2 2016+1.9%-0.1%-7.5%
Q1 2016+2.9%
Q4 2015+11.2%
Q3 2015-13.8%
Q2 2015-14.1%
Q1 2015+15.3%
Q4 2014-13.2%
Q3 2014+14.4%
Q2 2014+4.9%
Q1 2014-10.7%
Q4 2013+7.3%
Q3 2013+13.5%
Q2 2013-0.2%
Q1 2013+7.8%
Q4 2012-17.1%
Q3 2012-1.7%
Q2 2012-1.1%
Q1 2012+0.0%
Q4 2011-0.5%
Q3 2010-2.7%
Q3 2011-2.7%
Q2 2010-2.7%
Q2 2011-2.7%
Q1 2011+4.8%
Q4 2010-4.8%
Q1 2010+6.1%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro